This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pan, W. Articles by Grafström, R. H. Search for Related Content PubMed PubMed Citation Articles by Pan, W. Articles by Grafström, R. H.

A Cyclin D1/Cyclin-dependent Kinase 4 Binding Site within the C Domain of the Retinoblastoma Protein

Genetics and Cancer Group, DuPont Pharmaceutical Company, Glenolden Laboratory, Glenolden, PA 19036 [W. P., S. C., R. H. G.], and Applied Biotechnology Group, DuPont Pharmaceutical Company, Experimental Station, Wilmington, DE 19880 [R. H. H.]

Phosphorylation of the retinoblastoma protein (Rb) by the cyclin D1/cyclin-dependent kinase (cdk) 4 complex (cdk4/D1) is a key regulatory step for maintaining the orderly progression of the cell cycle. The B domain of Rb contains a site that recognizes and binds the LXCXE motif found in D-type cyclins. This interaction is important for phosphorylation of Rb by cdk4/D1, although in vitro the Rb C domain alone is efficiently phosphorylated by cdk4/D1. A mutation in the C domain of Rb, L901Q, has been identified that completely abolishes cdk4/D1 phosphorylation of the isolated C domain. By contrast, the L901Q mutation has no effect on phosphorylation by either cyclin E/cdk2 or cyclin B/cdk1, suggesting that the interaction between L901Q and cdk4/D1 is specific. Introduction of the L901Q mutation into Rb containing the A, B, and C domains results in phosphorylation becoming predominantly dependent on the LXCXE binding region. However, when the LXCXE binding region of Rb is mutated, phosphorylation becomes dependent on the L901 site within the C domain. The L901 binding site can supplant the LXCXE binding site for the cdk4/D1-dependent phosphorylation of S780 and S795 but not S807/S811. Despite the limited homology between C domains of Rb, p107, and p130, the L901 site is conserved and introduction of the L925Q mutation into the isolated C domain of p107 also inhibits phosphorylation by cdk4/D1. These data support a model for cdk4/D1 recognizing two independent binding sites in Rb and suggests a conservation of this C domain binding motif for cyclin D1/cdk4 kinase among the Rb family of proteins.

This article has been cited by other articles:

				P. J. Day, A. Cleasby, I. J. Tickle, M. O'Reilly, J. E. Coyle, F. P. Holding, R. L. McMenamin, J. Yon, R. Chopra, C. Lengauer, et al. Crystal structure of human CDK4 in complex with a D-type cyclin PNAS, March 17, 2009; 106(11): 4166 - 4170. [Abstract] [Full Text] [PDF]

				A. F. Arechiga, B. D. Bell, S. Leverrier, B. M. Weist, M. Porter, Z. Wu, Y. Kanno, S. J. Ramos, S. T. Ong, R. Siegel, et al. A Fas-Associated Death Domain Protein/Caspase-8-Signaling Axis Promotes S-Phase Entry and Maintains S6 Kinase Activity in T Cells Responding to IL-2 J. Immunol., October 15, 2007; 179(8): 5291 - 5300. [Abstract] [Full Text] [PDF]

				Z. Yu, J. Lin, Y. Xiao, J. Han, X. Zhang, H. Jia, Y. Tang, and Y. Li Induction of Cell-Cycle Arrest by all-trans Retinoic Acid in Mouse Embryonic Palatal Mesenchymal (MEPM) Cells Toxicol. Sci., February 1, 2005; 83(2): 349 - 354. [Abstract] [Full Text] [PDF]

				R. S. Abraham, K. V. Ballman, A. Dispenzieri, D. E. Grill, M. K. Manske, T. L. Price-Troska, N. G. Paz, M. A. Gertz, and R. Fonseca Functional gene expression analysis of clonal plasma cells identifies a unique molecular profile for light chain amyloidosis Blood, January 15, 2005; 105(2): 794 - 803. [Abstract] [Full Text] [PDF]

				A. Chytil, M. Waltner-Law, R. West, D. Friedman, M. Aakre, D. Barker, and B. Law Construction of a Cyclin D1-Cdk2 Fusion Protein to Model the Biological Functions of Cyclin D1-Cdk2 Complexes J. Biol. Chem., November 12, 2004; 279(46): 47688 - 47698. [Abstract] [Full Text] [PDF]

				M. Wallace and K. L. Ball Docking-Dependent Regulation of the Rb Tumor Suppressor Protein by Cdk4 Mol. Cell. Biol., June 15, 2004; 24(12): 5606 - 5619. [Abstract] [Full Text] [PDF]

				C. Hamdouchi, H. Keyser, E. Collins, C. Jaramillo, J. E. De Diego, C. D. Spencer, J. A. Dempsey, B. D. Anderson, T. Leggett, N. B. Stamm, et al. The discovery of a new structural class of cyclin-dependent kinase inhibitors, aminoimidazo[1,2-a]pyridines Mol. Cancer Ther., January 1, 2004; 3(1): 1 - 9. [Abstract] [Full Text]

				G. A. Darnell, T. M. Antalis, R. W. Johnstone, B. W. Stringer, S. M. Ogbourne, D. Harrich, and A. Suhrbier Inhibition of Retinoblastoma Protein Degradation by Interaction with the Serpin Plasminogen Activator Inhibitor 2 via a Novel Consensus Motif Mol. Cell. Biol., September 15, 2003; 23(18): 6520 - 6532. [Abstract] [Full Text] [PDF]

				M. M. Kavurma and L. M. Khachigian Sp1 Inhibits Proliferation and Induces Apoptosis in Vascular Smooth Muscle Cells by Repressing p21WAF1/Cip1 Transcription and Cyclin D1-Cdk4-p21WAF1/Cip1 Complex Formation J. Biol. Chem., August 29, 2003; 278(35): 32537 - 32543. [Abstract] [Full Text] [PDF]

				D. Ma, P. Zhou, and J. W. Harbour Distinct Mechanisms for Regulating the Tumor Suppressor and Antiapoptotic Functions of Rb J. Biol. Chem., May 23, 2003; 278(21): 19358 - 19366. [Abstract] [Full Text] [PDF]